Cargando…
Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
OBJECTIVE: To analyze the expression of hypoxia-inducible factors (hypoxia-inducible factor 1A and hypoxia-inducible factor 2A) and aldehyde dehydrogenase proteins in patients with locally advanced breast carcinoma who were subjected to neoadjuvant chemotherapy. METHODS: We included 90 patients with...
Autores principales: | Tiezzi, Daniel Guimarães, Clagnan, Willian Simões, Mandarano, Larissa Raquel Mouro, de Sousa, Christiani Bisinoto, Marana, Heitor Ricardo Cosiski, Tiezzi, Marcelo Guimarães, de Andrade, Jurandyr Moreira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654340/ https://www.ncbi.nlm.nih.gov/pubmed/23778413 http://dx.doi.org/10.6061/clinics/2013(05)03 |
Ejemplares similares
-
Expression of Hypoxia-inducible factor 1-α and Vascular endothelial growth factor–C in locally advanced breast cancer patients
por: Brito, Luiz Gustavo Oliveira, et al.
Publicado: (2011) -
HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination
por: Tiezzi, Daniel G, et al.
Publicado: (2007) -
Identification of a Subtype of Poorly Differentiated Invasive Ductal Carcinoma of the Breast Based on Vimentin and E-cadherin Expression
por: Orlandini, Leonardo Fleury, et al.
Publicado: (2018) -
Development of New Formulations of Biologics: Expectations, Immunogenicity, and Safety for Subcutaneous Trastuzumab
por: Pimentel, Franklin Fernandes, et al.
Publicado: (2018) -
Current Breast Cancer Screening Scenario in Brazil
por: Tiezzi, Daniel Guimarães, et al.
Publicado: (2019)